101 related articles for article (PubMed ID: 1986786)
21. Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives.
Radić Z; Reiner E; Taylor P
Mol Pharmacol; 1991 Jan; 39(1):98-104. PubMed ID: 1987454
[TBL] [Abstract][Full Text] [Related]
22. Asp7O in the peripheral anionic site of human butyrylcholinesterase.
Masson P; Froment MT; Bartels CF; Lockridge O
Eur J Biochem; 1996 Jan; 235(1-2):36-48. PubMed ID: 8631355
[TBL] [Abstract][Full Text] [Related]
23. Two-hydronic-reactive states of acetylcholinesterase, mechanistically relevant acid-base catalyst of pKa 6.5 and a modulatory group of pKa 5.5.
Salih E
Biochim Biophys Acta; 1991 Jan; 1073(1):183-94. PubMed ID: 1991134
[TBL] [Abstract][Full Text] [Related]
24. Trp82 and Tyr332 are involved in two quaternary ammonium binding domains of human butyrylcholinesterase as revealed by photoaffinity labeling with [3H]DDF.
Nachon F; Ehret-Sabatier L; Loew D; Colas C; van Dorsselaer A; Goeldner M
Biochemistry; 1998 Jul; 37(29):10507-13. PubMed ID: 9671522
[TBL] [Abstract][Full Text] [Related]
25. Energetics of ligand and inhibitor interactions with acetylcholinesterase.
Das YT; Brown HD; Chattopadhyay SK
Biochem Cell Biol; 1987 Sep; 65(9):798-802. PubMed ID: 3440086
[TBL] [Abstract][Full Text] [Related]
26. Selective labeling of anionic binding sites of the acetylcholinesterase from Torpedo californica with a photoaffinity label.
Layer P; Kiefer HR; Hucho F
Mol Pharmacol; 1976 Nov; 12(6):958-65. PubMed ID: 1004492
[No Abstract] [Full Text] [Related]
27. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.
Masson P; Froment MT; Bartels CF; Lockridge O
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):53-61. PubMed ID: 9224629
[TBL] [Abstract][Full Text] [Related]
28. Thermal inactivation of butyrylcholinesterase and acetylcholinesterase.
Burgess SK; Oxendine SL
J Protein Chem; 1993 Dec; 12(6):651-8. PubMed ID: 8136015
[TBL] [Abstract][Full Text] [Related]
29. Ligand stabilization of cholinesterases.
Payne CS; Saeed M; Wolfe AD
Biochim Biophys Acta; 1989 Nov; 999(1):46-51. PubMed ID: 2804138
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
[TBL] [Abstract][Full Text] [Related]
31. Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters.
Masson P; Froment MT; Fortier PL; Visicchio JE; Bartels CF; Lockridge O
Biochim Biophys Acta; 1998 Sep; 1387(1-2):41-52. PubMed ID: 9748494
[TBL] [Abstract][Full Text] [Related]
32. Labeling of cysteine 231 in acetylcholinesterase from Torpedo nobiliana by the active-site directed reagent, 1-bromo-2-[14C] pinacolone. Effects of 2,2'-dipyridyl disulfide and other sulfhydryl reagents.
Salih E; Howard S; Chishti SB; Cohen SG; Liu WS; Cohen JB
J Biol Chem; 1993 Jan; 268(1):245-51. PubMed ID: 8416933
[TBL] [Abstract][Full Text] [Related]
33. Oxadiazolidinones: irreversible inhibition of cholinesterases and effects on acetylcholine receptors.
Bakry NM; Sherby SM; Eldefrawi AT; Eldefrawi ME
Neurotoxicology; 1986; 7(3):1-10. PubMed ID: 3822252
[TBL] [Abstract][Full Text] [Related]
34. Allosteric effects of phenyltrimethylammonium and propidium on acetylcholinesterase active site.
Stalc A; Sentjurc M; Pecar S
Pflugers Arch; 1996; 431(6 Suppl 2):R277-8. PubMed ID: 8739372
[TBL] [Abstract][Full Text] [Related]
35. Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.
Campiani G; Fattorusso C; Butini S; Gaeta A; Agnusdei M; Gemma S; Persico M; Catalanotti B; Savini L; Nacci V; Novellino E; Holloway HW; Greig NH; Belinskaya T; Fedorko JM; Saxena A
J Med Chem; 2005 Mar; 48(6):1919-29. PubMed ID: 15771436
[TBL] [Abstract][Full Text] [Related]
36. Aggregating factor from Torpedo electric organ induces patches containing acetylcholine receptors, acetylcholinesterase, and butyrylcholinesterase on cultured myotubes.
Wallace BG
J Cell Biol; 1986 Mar; 102(3):783-94. PubMed ID: 3949878
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase.
Zhu J; Wu CF; Li X; Wu GS; Xie S; Hu QN; Deng Z; Zhu MX; Luo HR; Hong X
Bioorg Med Chem; 2013 Jul; 21(14):4218-24. PubMed ID: 23719283
[TBL] [Abstract][Full Text] [Related]
38. Identification of agrin, a synaptic organizing protein from Torpedo electric organ.
Nitkin RM; Smith MA; Magill C; Fallon JR; Yao YM; Wallace BG; McMahan UJ
J Cell Biol; 1987 Dec; 105(6 Pt 1):2471-8. PubMed ID: 2826489
[TBL] [Abstract][Full Text] [Related]
39. Biochemical evaluation of photolabile precursors of choline and of carbamylcholine for potential time-resolved crystallographic studies on cholinesterases.
Peng L; Silman I; Sussman J; Goeldner M
Biochemistry; 1996 Aug; 35(33):10854-61. PubMed ID: 8718877
[TBL] [Abstract][Full Text] [Related]
40. Substrate activation of butyrylcholinesterase and substrate inhibition of acetylcholinesterase by 3,3-dimethylbutyl-N-n-butylcarbamate and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
Chiou SY; Wu YG; Lin YF; Lin LY; Lin G
J Biochem Mol Toxicol; 2007; 21(1):24-31. PubMed ID: 17366539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
